• PeopleBio’s board resolved on Oct. 30, 2026, to extend collateral support for two parties related to a major shareholder.
• The collateral amount is KRW 61.09 billion, equivalent to 213.48% of equity, securing KRW 49.47 billion in borrowings.
• The extension runs from Oct. 30, 2026, through Jan. 4, 2027, using land and buildings in Seoul’s Gangnam district.
• Total outstanding collateral provided for others stands at KRW 71.94 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PeopleBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030901038), on October 30, 2026, and is solely responsible for the information contained therein.